Results 201 to 210 of about 58,334 (260)

Assay method development and validation for celecoxib dosage forms by high performance liquid chromatography

, 2016
O.S.S. Chandana, R. Ravichandrababu
openalex   +1 more source

Flufenamic acid-based sulfonohydrazide and acetamide derivatives NSAI as inhibitors of multi-targets COX-1/COX-2/5-LOX: design, synthesis, in silico ADMET and binding mode studies. [PDF]

BMC Chem
Hussein S, Fayed EA, Ragab A, Abusaif MS, Ammar YA, El-Sayed Mansou R, Musa A, Ramsis TM.   +7 more
europepmc   +1 more source

Beyond Pain Relief: A Cross-Sectional Study on NSAID Prescribing, Polypharmacy, and Drug Interaction Risks in Community Pharmacies. [PDF]

Healthcare (Basel)
Shareef J, Sridhar SB, Al Naqbi SH, Bakshi AI.   +3 more
europepmc   +1 more source

COX-2 inhibition synergizes with radioimmunotherapy by promoting TCF1⁺CD8⁺ T cell infiltration in NSCLC. [PDF]

Cancer Biol Med
Ma L, Bai M, Wang Y, Zhai X, Yu J, Meng X.   +5 more
europepmc   +1 more source

Phthalimide Derivatives as Anti-Inflammatory Agents: In Silico COX-2 Targeting and In Vitro Inhibition of PGE₂ Production. [PDF]

Pharmaceutics
Heras Martínez HM, Sánchez-Ramírez B, Landeros-Martínez LL, Rodríguez-Guerrero D, Espinoza-Hicks JC, Zaragoza-Galán G, Bugarin A, Chávez-Flores D.   +7 more
europepmc   +1 more source

A prospective, randomized, double-blind, multicenter comparative study on the safety and efficacy of Celecoxib and GCSB-5, dried extracts of six herbs, for the treatment of osteoarthritis of knee joint

, 2013
Yong‐Geun Park, Chul‐Won Ha, Chang-Dong Han, Seong‐Il Bin, Hee-Chun Kim, Young‐Bok Jung, Hong-Chul Lim   +6 more
openalex   +2 more sources

Correction: Park, Y.-B.; Kim, J.-H. Efficacy and Safety of Celecoxib and a Korean SYSADOA (JOINS) for the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis. <i>J. Clin. Med.</i> 2025, <i>14</i>, 1036. [PDF]

J Clin Med
Park YB, Kim JH.
europepmc   +1 more source

Neoadjuvant PD-1 blockade with toripalimab with or without celecoxib for patients with mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): long-term outcomes of a single-centre, parallel-group, non-comparative, randomised phase 2 trial. [PDF]

EClinicalMedicine
Shen X, Cai Y, Li W, Shi L, Zhang J, Xie X, Wu Z, Zheng Z, Cao W, Deng Y, Hu H.   +10 more
europepmc   +1 more source

Auckland’s Cancer Cachexia evaluating Resistance Training (ACCeRT) main study results [PDF]

, 2019
Bird, Stephen P., Keogh, Justin W L, MacLeod, Roderick D., Rogers, Elaine S., Sasidharan, Rita, Sequeira, Graeme, Stewart, Joanna, Wood, Matthew R.   +7 more
core